Treatment of anastomotic leak after oesophagectomy for oesophageal cancer: large, collaborative, observational TENTACLE cohort study
| Autor: | Ubels, S., Verstegen, M.H.P., Klarenbeek, B.R., Bouwense, S., Berge Henegouwen, M.I. van, Daams, F., Det, M.J. van, Griffiths, E.A., Haveman, J.W., Heisterkamp, J., Nieuwenhuijzen, G., Polat, F., Schouten, J.A., Siersema, P.D., Singh, P., Wijnhoven, B., Hannink, G.J., Workum, F.T.W.E. van, Rosman, C. |
|---|---|
| Rok vydání: | 2023 |
| Předmět: |
Reconstructive and regenerative medicine Radboud Institute for Health Sciences [Radboudumc 10]
Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14] All institutes and research themes of the Radboud University Medical Center lnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4] Metabolic Disorders Radboud Institute for Molecular Life Sciences [Radboudumc 6] |
| Zdroj: | British Journal of Surgery, 110, 7, pp. 852-863 |
| Popis: | Contains fulltext : 294540.pdf (Publisher’s version ) (Open Access) BACKGROUND: Anastomotic leak is a severe complication after oesophagectomy. Anastomotic leak has diverse clinical manifestations and the optimal treatment strategy is unknown. The aim of this study was to assess the efficacy of treatment strategies for different manifestations of anastomotic leak after oesophagectomy. METHODS: A retrospective cohort study was performed in 71 centres worldwide and included patients with anastomotic leak after oesophagectomy (2011-2019). Different primary treatment strategies were compared for three different anastomotic leak manifestations: interventional versus supportive-only treatment for local manifestations (that is no intrathoracic collections; well perfused conduit); drainage and defect closure versus drainage only for intrathoracic manifestations; and oesophageal diversion versus continuity-preserving treatment for conduit ischaemia/necrosis. The primary outcome was 90-day mortality. Propensity score matching was performed to adjust for confounders. RESULTS: Of 1508 patients with anastomotic leak, 28.2 per cent (425 patients) had local manifestations, 36.3 per cent (548 patients) had intrathoracic manifestations, 9.6 per cent (145 patients) had conduit ischaemia/necrosis, 17.5 per cent (264 patients) were allocated after multiple imputation, and 8.4 per cent (126 patients) were excluded. After propensity score matching, no statistically significant differences in 90-day mortality were found regarding interventional versus supportive-only treatment for local manifestations (risk difference 3.2 per cent, 95 per cent c.i. -1.8 to 8.2 per cent), drainage and defect closure versus drainage only for intrathoracic manifestations (risk difference 5.8 per cent, 95 per cent c.i. -1.2 to 12.8 per cent), and oesophageal diversion versus continuity-preserving treatment for conduit ischaemia/necrosis (risk difference 0.1 per cent, 95 per cent c.i. -21.4 to 1.6 per cent). In general, less morbidity was found after less extensive primary treatment strategies. CONCLUSION: Less extensive primary treatment of anastomotic leak was associated with less morbidity. A less extensive primary treatment approach may potentially be considered for anastomotic leak. Future studies are needed to confirm current findings and guide optimal treatment of anastomotic leak after oesophagectomy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|